Work

Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present

Year: 2014

Type: review

Source: Expert Opinion on Investigational Drugs

DOI: 10.1517/13543784.2014.867017

Authors: Mathew C Casimiro, Marco Velasco-Velázquez, Charmina Aguirre-Alvarado, Richard G Pestell

Institutions: Thomas Jefferson University, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, Universidad Nacional Autónoma de México

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Impact of Cyclin D1 Isoforms in Breast Cancer, Androgen Receptor Function in Prostate Cancer, Initiation and Maintenance in Mammary Tumorigenesis, Regulation of cyclin D1 Expression, DACH1/Eya Cell fate determination factor and mammary tumorigenesis, Translational Research in Cancer

OpenAlex ID: W2019956469

FWCI: 3.615

Cites: 125

Cited by: 183

Related to: 10